MGMT and neoplasm: Higher tumor grade, older age [33], and increased expression of molecular biomarkers such as P53 [40], MGMT [41], PR [42], IDH1-wildtype [43], H3K27M mutation of pediatric HGG [44, 45], and Ki-67 [46], were related to poorer prognoses.